Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Mucosal Immunity
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1543059

Detection of chimeric alpha-defensin transcripts and peptides in mouse Paneth cells

Provisionally accepted
Steven Timmermans Steven Timmermans 1,2*Charlotte Wallaeys Charlotte Wallaeys 1,2Somara De Beul Somara De Beul 1,2Natalia Garcia Gonzalez Natalia Garcia Gonzalez 1,2Claude Libert Claude Libert 1,2*
  • 1 Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium
  • 2 Ghent University, Ghent, East Flanders, Belgium

The final, formatted version of the article will be published soon.

    In mammals, Paneth cells, located in the crypts of the small intestine, produce antimicrobial peptides that keep the intestinal microbes under control. α-Defensins are the primary antimicrobial peptides produced by these cells. Bulk mRNA-seq on mouse Paneth cells reveals the existence of 28 protein coding Defa genes in mice, which is much greater than the amount of Defa genes in other species checked. Across our 148 bulk RNA-seq samples from sorted Paneth cells, approximately 85% of the total Paneth cell reads are assigned to Defa genes. Interestingly, we detected mRNAs composed of sequences from two different Defa genes. They are found in most of our experiments, and most of the 28 Defa gene mRNAs are involved in such chimeric Defa mRNAs. We estimate that the sum of all chimeric mRNAs does not exceed 0.3% of all Paneth cell mRNAs, which is not to be neglected. Even though the chimeric mRNAs are relatively unabundant, we did find chimeric peptides in Paneth cells by Mass Spectrometry. Finally, synthetic chimeric peptides appeared to have biological activity in lysing four different bacterial species.

    Keywords: Alpha-defensin, Chimer protein, Mus musculus, Paneth cell, Anti-microbial activities

    Received: 10 Dec 2024; Accepted: 20 Jan 2025.

    Copyright: © 2025 Timmermans, Wallaeys, De Beul, Garcia Gonzalez and Libert. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Steven Timmermans, Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium
    Claude Libert, Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, Belgium

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.